Viatris (MEX:MYL) Other Current Payables : MXN10,394 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Viatris Other Current Payables?

Viatris's Other Current Payables for the quarter that ended in Dec. 2024 was MXN10,394 Mil.

Viatris's quarterly Other Current Payables increased from Jun. 2024 (MXN10,534 Mil) to Sep. 2024 (MXN13,462 Mil) but then declined from Sep. 2024 (MXN13,462 Mil) to Dec. 2024 (MXN10,394 Mil).

Viatris's annual Other Current Payables declined from Dec. 2022 (MXN12,304 Mil) to Dec. 2023 (MXN9,451 Mil) but then increased from Dec. 2023 (MXN9,451 Mil) to Dec. 2024 (MXN10,394 Mil).

Viatris Other Current Payables Historical Data

The historical data trend for Viatris's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Other Current Payables Chart

Viatris Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Payables

Get a 7-Day Free Trial

11,109.68

12,335.07

12,303.93

9,451.26

10,394.48

Viatris Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Current Payables	Get a 7-Day Free Trial															9,451.26	10,171.85	10,534.06	13,462.26	10,394.48

Viatris Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Viatris Other Current Payables Related Terms

Thank you for viewing the detailed overview of Viatris's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Viatris Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (MEX:MYL) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

VTRS:USA 1VTRS:Italy 0A5V:UK VIA:Germany VIA:Germany VIA:Germany VIA:Germany MYL:Austria

Address

1000 Mylan Boulevard, Canonsburg, PA, USA, 15317

Website

https://www.viatris.com

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris Headlines

No Headlines